Clinical trial

Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn's Disease

Name
BRONDEL Ass INRA 2011
Description
This study will improve our understanding of the mechanisms underlying anorexia in persons with Crohn's disease flare-ups. The practical spin-off from this research is potentially very important for the management of nutritional disorders associated with the disease by guiding diets towards foods that correspond to patients' preferences and/or to modified tastes. In addition, the results could lead to the identification of sensory markers that herald an inflammatory flare-up of the disease.
Trial arms
Trial start
2013-10-07
Estimated PCD
2021-05-03
Trial end
2021-05-03
Status
Completed
Treatment
triangular test
metabolic state, impedance measurement, potential flavours evoked by sucrose,
Arms:
Control, Crohn and anti-TNF treatment, Crohn and without anti-TNF treatment
blood sampling
sampling of 2 mL
Arms:
Control, Crohn and anti-TNF treatment, Crohn and without anti-TNF treatment
Questionnaires
Stunkard, PrefQuest
Arms:
Control, Crohn and anti-TNF treatment, Crohn and without anti-TNF treatment
Size
62
Primary endpoint
Modification of sweet taste
through the study completion up to 10 years
Eligibility criteria
For patients : Inclusion Criteria: * Age between 18 and 60 years, * Diagnosis of Crohn's disease according to clinical, endoscopic, histological, radiological and biochemical criteria as defined by the European Consensus Conference, * Men or women who have provided consent and willing to cooperate. Exclusion Criteria: * Chronic inflammatory intestinal disease (CIID) other than Crohn's disease: haemorrhagic rectocolitis, undetermined colitis, microscopic colitis. * Intercurrent disease (diabetes and metabolic disease, liver cirrhosis, progressive cancer, acute or chronic infection, Human Immunodeficiency Virus HIV), * Organ failure (respiratory, heart, or renal failure, neurological disorders), * Intolerance to gluten, * Treatments (other than those used for Crohn's disease) able to interfere with food intake, * Aversion to foods consumed or smelled, * Poor understanding of cognitive tasks required. * Crohn's disease complicated by an abscess or infectious complication * Acute Crohn's disease defined by a CDAI score \> 150 For Controls: Inclusion Criteria: * Adult person * Without follow-up for a chronic pathology * Having given its consent Exclusion Criteria: * Protected adult * Person not affiliated to a social security system * Pregnant or breastfeeding woman * Active smoker * No one who does not speak French * Taking treatment that interferes with taste or acts on the central nervous system
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'CASE_ONLY', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 62, 'type': 'ACTUAL'}}
Updated at
2024-02-22

1 organization

1 product

2 indications

Indication
Crohn's disease